Comment: ..

(See in situ)

In reply to comment: have done extensive research (see in situ)

..

Reported Dec 17, 2012
A confidential GlaxoSmithKline document recently leaked to the press exposed that within a two-year period, a total of 36 infants died after receiving the 6-in-1 vaccine, Infanrix Hexa. [1] According to the website Initiative Citoyenne [2] who reported the news, the 1271 page document revealed that GlaxoSmithKline received a total of 1,742 reports of adverse reactions between October 23, 2009, and October 22, 2011, including 503 serious adverse reactions and 36 deaths. Initiative Citoyenne stated:

It’s not that 14 deaths were recorded by GSK between October 2009 and end in October 2011 as we had originally calculated but 36 (14 from 2010 to 2011 and 22 from 2009 to 2010). In addition to these 36 deaths at least 37 other deaths (sudden death mainly), bringing the total to at least 73 deaths since the launch of the vaccine in 2000, and again, this concerns only the death by sudden death, no further recovery of under-reporting.

Using the figure of 36 deaths over a two-year period, this averages 1.5 deaths per month, which by anyone’s standard is extremely high. Note that only 1 to 10% of adverse reactions to vaccines are actually reported. Therefore, in reality, the problem could potentially be far more serious and the actual number of fatalities much higher.

THE DEADLY CHEMICAL COCKTAIL

The charts show that many of the babies who died passed away within the first few days of receiving the vaccine. [3] A total of three infants were reported to have died within hours of receiving the vaccine.

This tragedy is hardly surprising given the vaccine’s ingredients listed on the GSK Infanrix Hexa product information leaflet, which parents are rarely given the chance to read prior to vaccination, including non-infectious substances from tetanus, diphtheria bacteria, purified proteins of pertussis bacteria, the surface protein of the hepatitis B virus (HBsAg, derived from genetically engineered yeast cells) and inactivated poliovirus. [4] Each 0.5mL dose contains:

diphtheria toxoid
tetanus toxoid
pertussis toxoid
filamentous haemagglutinin
pertactin
recombinant HBsAg protein
poliovirus Type 1
poliovirus Type 2
poliovirus Type 3
purified capsular polysaccharide of Hib covalently bound to tetanus toxoid
aluminium hydroxide
aluminium phosphate
2-phenoxyethanol, lactose
Medium 199
neomycin
polymyxin
polysorbate 80
polysorbate 20
sodium chloride
water